Hollis-Eden Pharmaceuticals News
Most Popular Hollis-Eden Pharmaceuticals Story
Emerging Drug Developer: Hollis-Eden
When Richard Hollis got up on March 7, he was the CEO of a company that was primarily known for its work advancing Neumune, a therapy for acute radiation syndrome and a prime candidate for Read more...
Latest Headlines
- March 24, 2009
- February 3, 2009
- September 7, 2007
- August 31, 2007
- August 30, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
